Results 201 to 210 of about 17,177 (315)

Circ_0006174 Drives Triple Negative Breast Cancer Progression and Immune Escape Through Regulating miR‐3139/PD‐L1 Axis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Triple‐negative breast cancer (TNBC) is characterized as an aggressive malignancy with limited therapeutic options. The circular RNA circ_0006174 has been implicated in oncogenic processes across various cancers; however, its specific role in the pathogenesis of TNBC remains unclear.
Yong‐Zhe Tang, Li Yang, Ling Wang, Xiao‐Qing Zhang, Jie Wang   +4 more
wiley   +1 more source

Aesthetic Leadership in Nursing: A Theoretical Proposal for Rehumanizing Care Delivery. [PDF]

Nurs Inq
Monge Moreno JT.
europepmc   +1 more source

Building Successful Team Interaction in Online Team Coaching Process: A Case Study

Knowledge and Process Management, EarlyView.
ABSTRACT In the post‐COVID‐19 era, work has expanded to multiple locations with teams operating increasingly online, where successful team interaction between colleagues is a more challenging task. Thus, this study explores factors in online team coaching that build successful team interaction.
Eija‐Liisa Heikka, Eeva‐Liisa Oikarinen   +1 more
wiley   +1 more source

Neutralization of the Pandemic Influenza A/H1N1 Virus with <i>Lama glama</i> Humanized Nanobodies (VHH). [PDF]

Antibodies (Basel)
Páez-Hernández ZY, Stephano-Hornedo JL, Bolaños-Prats JA, Córdova-Guerrero I, Macías-Alonso M, Marrero JG, Capiz AP, González VG.   +7 more
europepmc   +1 more source

The Contribution of Experiential Learning and Sensemaking to the Development of Dynamic Capabilities in Contexts of Planned Organizational Change: A Multiple Case Study in Brazilian Companies

Knowledge and Process Management, EarlyView.
ABSTRACT This article explores how the interaction between experiential learning and sensemaking helps organizations develop dynamic capabilities essential for maintaining a competitive advantage during turbulent planned changes. It clarifies the microprocesses through which leaders and teams sense, seize, and transform opportunities in emerging market
Adriana Locatelli Bertolini, Fabiano Larentis, Vilmar Antonio Gonçalves Tondolo   +2 more
wiley   +1 more source

RO4, a high-affinity humanized antibody against the juxtamembrane region of mesothelin for targeted cancer therapy. [PDF]

Antib Ther
Onda M, Liu X, Liu W, Zhan J, Maslanka CA, Xia D, Ho M, Pastan I.   +7 more
europepmc   +1 more source

AI Epistemic Disengagement and Consumer Dependence: An Augmentation‐Substitution Framework

Psychology &Marketing, EarlyView.
ABSTRACT Artificial intelligence has become consumers' primary decision‐making resource, raising two questions: how do consumers justify accepting AI as a trusted source of reasoning, and when does this acceptance maintain rather than forfeit their capacity to think independently?
Vasilis Theoharakis, Nikolaos Mylonopoulos   +1 more
wiley   +1 more source

Novel Autologous Regulatory T-Cell Therapy Ameliorates DSS-Induced Colitis in Humanized Mice. [PDF]

Inflamm Bowel Dis
Khan MJ, Lee YJ, Lee SY, Chung H, Nguyen-Phuong T, Kim YH, Park CG, Kang YM.   +7 more
europepmc   +1 more source

An Open‐Label Phase 1b Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ANX005 in Patients with Huntington's Disease

Movement Disorders, EarlyView.
Complement activation is implicated in Huntington's disease; ANX005 is a potent inhibitor of component C1q. ANX005 exhibited a generally manageable safety profile with rapid reduction in C1q in the cerebrospinal fluid. Functional ability on composite Unified Huntington's Disease Rating Scale and total functional capacity was maintained, with potential ...
Rajeev Kumar, Pinky Agarwal, Karen Anderson, Daniel Claassen, Marissa Dean, Andrew Duker, Burton Scott, Benjamin Hoehn, Ann Mongan, Ping Lin, Ellen Cahir‐McFarland, Lori Taylor, Glenn Morrison, Ted Yednock, Sanjay Keswani, Henk‐Andre Kroon   +15 more
wiley   +1 more source

VNAR: shark single-domain antibodies for the new era of medical biotechnology. [PDF]

Front Immunol
Olivares-Olivares RA, Bravo AR, Garrido-Soto C, Carvajal JJ, Manubens A, Rivas M, Bustamente C, Retamal-Díaz A, Kalergis AM, Lay MK.   +9 more
europepmc   +1 more source